AM-Pharma
Biotechnology ResearchUtrecht, Netherlands11-50 Employees
AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use.
Insights
Key Personnel Expansion AM-Pharma has recently strengthened its leadership team by appointing key executives such as a new Chief Executive Officer, Chief Financial Officer, and Vice Presidents in strategic roles, indicating a focus on business growth and development.
Strategic Partnerships The partnership with KBI Biopharma Inc. for commercial manufacturing of AM-Pharma's therapeutics presents an opportunity to leverage this collaboration to access KBI Biopharma's network and potentially explore cross-selling opportunities to mutual clients.
Acquisition by Pfizer Although Pfizer initially acquired a minority stake in AM-Pharma, the subsequent acquisition and the decision to decline full acquisition in 2018 suggest that there could be avenues for collaboration or sales partnerships between the two companies, especially in aligning product strategies.
Competitive Benchmarking By studying similar companies such as National Enzyme Company and Formulated Solutions, AM-Pharma can gain insights into their market positioning, revenue streams, and sales strategies to refine its own sales approach and identify potential areas for differentiation and growth.
Industry Expertise Given AM-Pharma's focus on developing therapeutics for severe medical conditions and the expertise of its leadership team, the company is well-positioned to leverage its industry knowledge to engage with healthcare providers, institutions, and regulatory bodies, potentially leading to increased sales and market penetration.
AM-Pharma Tech Stack
AM-Pharma uses 8 technology products and services including jQuery CDN, Shopify, Google Font API, and more. Explore AM-Pharma's tech stack below.
- jQuery CDNContent Delivery Network
- ShopifyE-commerce
- Google Font APIFont Scripts
- RSSMiscellaneous
- PHPProgramming Languages
- MediaElement.jsVideo Players
- YouTubeVideo Players
- NginxWeb Servers
Media & News
AM-Pharma's Email Address Formats
AM-Pharma uses at least 1 format(s):
| AM-Pharma Email Formats | Percentage |
| F.Last@am-pharma.com | 82% |
| First-Last@am-pharma.com | 8% |
| FirMLast@am-pharma.com | 5% |
| Last@am-pharma.com | 5% |
Frequently Asked Questions
Where is AM-Pharma's headquarters located?
AM-Pharma's main headquarters is located at Stadsplateau 6 Utrecht, 3521 AZ NL. The company has employees across 5 continents, including EuropeNorth AmericaAsia. What is AM-Pharma's phone number?
You can contact AM-Pharma's main corporate office by phone at +31-30-228-****
What is AM-Pharma's official website and social media links?
AM-Pharma's official website is am-pharma.com and has social profiles on LinkedIn.How much revenue does AM-Pharma generate?
As of February 2024, AM-Pharma's annual revenue reached $3.8M. What is AM-Pharma's SIC code NAICS code?
AM-Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does AM-Pharma have currently?
As of February 2024, AM-Pharma has approximately 21 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: J. B.Vice President Of Clinical Operations: K. B.Vice President Global Commercial Strategy & Business Development: M. N. M.. Explore AM-Pharma's employee directory with LeadIQ.What industry does AM-Pharma belong to?
AM-Pharma operates in the Biotechnology Research industry. What technology does AM-Pharma use?
AM-Pharma's tech stack includes jQuery CDNShopifyGoogle Font APIRSSPHPMediaElement.jsYouTubeNginx. What is AM-Pharma's email format?
AM-Pharma's email format typically follows the pattern of . Find more AM-Pharma email formats with LeadIQ. When was AM-Pharma founded?
AM-Pharma was founded in 2002.
Company Overview
- Headquarters
- Stadsplateau 6 Utrecht, 3521 AZ NL
- Phone number
- +31-30-228-****
- Website
- am-pharma.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2002
- Employees
- 11-50
Media & News
Funding & Financials
- $10M
AM-Pharma's revenue is in the range of $10M
Funding & Financials
- $10M
AM-Pharma's revenue is in the range of $10M
Company Leadership
J. B.Chief Executive Officer
K. B.Vice President Of Clinical Operations- M. N. M.Vice President Global Commercial Strategy & Business Development
- P. V.Vice President Finance
S. C.VP Dev & Manufacture
Employee Directory
- S. C.VP Dev & Manufacture
- W. M.Vice President Ra And Qm
- M. W.Sr. Director Clinical Data Management
- L. H.Sr Director Project Management Office
- S. V. D. B.Sr Director Finance
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
